Brexpiprazole in patients with schizophrenia with or without substance use disorder
An observational study
Bibliographic Data
| ID | 15522970 |
|---|---|
| Authors | Ginevra Lombardozzi (0009-0002-7039-1820, corresponding author), Giada Trovini (0000-0001-8711-5326), Emanuela Amici (0009-0003-5347-7160), Georgios D Kotzalidis (0000-0002-0281-6324, Azienda Ospedaliera Sant'Andrea, corresponding author), F Perrini (0000-0003-0789-8071, ASL Roma), Valeria Giovanetti (0009-0007-2842-9676), Alessandro Di Giovanni, Sergio De Filippi (0000-0002-6521-3379), Sergio De Filippis |
| Year | 2023 |
| Volume | 14 |
| Pages | 1321233-1321233 |
| Publication date | 2023-12-04 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1321233 |
| PMID | 38111619 |
| OpenAlex | W4389309712 |
| Language | EN |
| Citations received | 1 |
| References cited | 97 |
Treatment with brexpiprazole for 6 months improved psychotic symptoms in patients with schizophrenia, independently from whether they belonged to the SUD or the non-SUD group; hence, SUD comorbidity did not confer treatment resistance to brexpiprazole. Furthermore, in the SUD group, we observed reduced substance craving
Addiction · Agonist · Brief Psychiatric Rating Scale · Craving · Observational study · Partial agonist · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Rating scale · Schizophrenia (object-oriented programming · Substance abuse · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychology · Schizophrenia research and treatment · Internal Medicine
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |